Skip to main content
. 2017 May 22;127(7):2815–2828. doi: 10.1172/JCI91788

Figure 9. Chb-M′ as a safe lead compound of a potentially novel anticancer drug category.

Figure 9

Chb-M′ targets the consensus RUNX binding sequences on the genome DNA and achieves cluster regulation of RUNX target genes, which offers efficient antitumor activity through potentiating a proapoptotic p53-mediated cell death pathway.